SILK Stock Overview
Silk Road Medical, Inc operates as a medical device company in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Silk Road Medical, Inc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$17.57 |
| 52 Week High | US$45.09 |
| 52 Week Low | US$6.08 |
| Beta | 1.48 |
| 1 Month Change | -4.67% |
| 3 Month Change | 15.52% |
| 1 Year Change | -60.33% |
| 3 Year Change | -71.99% |
| 5 Year Change | -56.82% |
| Change since IPO | -51.44% |
Recent News & Updates
Recent updates
Silk Road Medical, Inc's (NASDAQ:SILK) Shares Leap 35% Yet They're Still Not Telling The Full Story
Feb 03
A Piece Of The Puzzle Missing From Silk Road Medical, Inc's (NASDAQ:SILK) 26% Share Price Climb
Dec 20Is Silk Road Medical (NASDAQ:SILK) Weighed On By Its Debt Load?
Nov 03Is Silk Road Medical (NASDAQ:SILK) A Risky Investment?
Aug 05Shareholders Should Be Pleased With Silk Road Medical, Inc's (NASDAQ:SILK) Price
May 05Is Silk Road Medical (NASDAQ:SILK) A Risky Investment?
Apr 04Silk Road Medical announces $100M common stock offering
Oct 17Is Silk Road Medical (NASDAQ:SILK) Using Too Much Debt?
Sep 24Silk Road Medical GAAP EPS of -$0.44 beats by $0.02, revenue of $33.17M beats by $2.14M
Jul 26Silk Road Medical: Divergence From Alternative Risk Premia Means Lack Of Upside Capture
Jul 19Silk Road Medical falls after Citigroup downgrades to Sell from Neutral
Jul 11Is Silk Road Medical (NASDAQ:SILK) Using Too Much Debt?
Jun 09Silk Road Medical - What A Road It Has Been
Apr 08Is Silk Road Medical (NASDAQ:SILK) Using Debt Sensibly?
Feb 23Silk Road Medical, Inc's (NASDAQ:SILK) Intrinsic Value Is Potentially 48% Above Its Share Price
Jan 24Is It Too Late To Consider Buying Silk Road Medical, Inc (NASDAQ:SILK)?
Dec 09Is Silk Road Medical (NASDAQ:SILK) Weighed On By Its Debt Load?
Nov 18Shareholder Returns
| SILK | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0.6% | 1.4% | 1.2% |
| 1Y | -60.3% | -0.7% | 24.7% |
Return vs Industry: SILK underperformed the US Medical Equipment industry which returned -3.7% over the past year.
Return vs Market: SILK underperformed the US Market which returned 19.3% over the past year.
Price Volatility
| SILK volatility | |
|---|---|
| SILK Average Weekly Movement | 7.3% |
| Medical Equipment Industry Average Movement | 7.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: SILK's share price has been volatile over the past 3 months.
Volatility Over Time: SILK's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 474 | Chas McKhann | silkroadmed.com |
Silk Road Medical, Inc operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization (TCAR). Its products comprise ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and establish temporary blood flow reversal; ENROUTE Transcarotid Stent System for transcarotid access; ENHANCE Transcarotid Peripheral Access Kit, which is used to gain initial access to the common carotid artery; ENROUTE 0.014 Guidewire for atraumatic vessel navigation and target lesion crossing for delivery of interventional devices; and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter, a transcarotid rapid exchange balloon for the TCAR procedure.
Silk Road Medical, Inc Fundamentals Summary
| SILK fundamental statistics | |
|---|---|
| Market cap | US$692.22m |
| Earnings (TTM) | -US$55.74m |
| Revenue (TTM) | US$177.13m |
3.9x
P/S Ratio-12.3x
P/E RatioIs SILK overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SILK income statement (TTM) | |
|---|---|
| Revenue | US$177.13m |
| Cost of Revenue | US$50.05m |
| Gross Profit | US$127.09m |
| Other Expenses | US$182.83m |
| Earnings | -US$55.74m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 30, 2024
| Earnings per share (EPS) | -1.42 |
| Gross Margin | 71.75% |
| Net Profit Margin | -31.47% |
| Debt/Equity Ratio | 50.0% |
How did SILK perform over the long term?
See historical performance and comparison